Advocating for Improved treatment and Outcomes for Wet Age-related Macular Degeneration. A report based on an International Expert Summit.
Expert Clinical Guide to the Management of Exudative Age-Related Macular Degeneration
Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report. 2013.
Intravitreal Injections: A Healthcare Failure Modes and Effects Analysis. 2013, Aug.
Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.
Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: a little-understood spectral domain optical coherence tomography finding.
FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and high visual acuity.
Update on Geographic Atrophy in Age-Related Macular Degeneration.
Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome.
Management of Retinal Vein Occlusion – Consensus Document.
Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Postsurgical cystoid macular edema
Retinal vein occlusions.
As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. (FALTA)